Cite

Copy

Chapter menu

Show all

Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Add to Home Screen/Install App' to create a shortcut app

ISPN GuideCongenital Disorders of the Nervous System in ChildrenMyelomeningoceles in Children HomepageReferences for Myelomeningoceles in Children

References for Myelomeningoceles in Children

This page was last updated on May 9th, 2017

  1. Dias MS, McLone DG: Myelomeningocele. in Albright AL, Pollack IF, Adelson PD (ed): Principles and practice of pediatric neurosurgery. New York: Thieme, 2008, pp338-366
  2. McClugage SG, Watanabe K, Shoja MM, et al. The history of the surgical repair of spina bifida. Childs Nerv Syst 28:1693-700, 2012
  3. Lorber J. Selective treatment of myelomeningocele: To treat or not to treat? Pediatrics 53:307-8, 1974
  4. Lorber J. Myelomeningocele; new approaches to its management. Nurs Times 70:272-3, 1974
  5. Lorber J. Results of treatment of myelomeningocele. An analysis of 524 unselected cases, with special reference to possible selection for treatment. Dev Med Child Neurol 13:279-303, 1971
  6. McLone DG. Treatment of myelomeningocele: arguments against selection. Clin Neurosurg 33:359-70, 1986
  7. McLone DG. Results of treatment of children born with a myelomeningocele. Clin Neurosurg 1983;30:407-12, 1983
  8. Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364:993-1004, 2011
  9. Rothenberg SP, da Costa MP, Sequeira JM, et al. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med 350:134-42. 2004
  10. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862-77, 2000
  11. Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262:2847-52, 1989
  12. O’Rahilly R, Muller F. The two sites of fusion of the neural folds and the two neuropores in the human embryo. Teratology 65:162-70, 2002
  13. Khoury MJ, Beaty TH, Liang KY. Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am J Epidemiol 127:674-83, 1988
  14. Melvin EC, George TM, Worley G, et al. Genetic studies in neural tube defects. NTD Collaborative Group. Pediatr Neurosurg 32:1-9, 2000
  15. George TM, Cummings TJ. The immunohistochemical profile of the myelomeningocele placode: is the placode normal? Pediatr Neurosurg 39:234-9, 2003
  16. Vujkovic M, Steegers EA, Looman CW, et al. The maternal Mediterranean dietary pattern is associated with a reduced risk of spina bifida in the offspring. BJOG 116:408-15, 2009
  17. Kaneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 33:145-58, 1999
  18. Corti G, Manzur T, Nagle C, et al. Etiopathology of Arnold-Chiari malformation: a fetal rat model of dysraphism. Fetal Diagn Ther 28:28-33, 2010
  19. Chatkupt S, Skurnick JH, Jaggi M, et al. Study of genetics, epidemiology, and vitamin usage in familial spina bifida in the United States in the 1990s. Neurology 44:65-70, 1994
  20. Copp AJ, Greene ND. Neural tube defects: prevention by folic acid and other vitamins. Indian J Pediatr 67:915-21, 2000
  21. Burger PC, Scheithauer BW, Vogel FS. Spine and epidural space, in Burger PC, Scheithauer BW, Vogel FS (eds): Surgical pathology of the nervous system and its coverings, ed 1. New York: Churchill Livingstone, 2002, pp 499-526
  22. Sakai Y. Neurulation in the mouse: manner and timing of neural tube closure. Anat Rec 223:194-203, 1989
  23. Rosenquist TH, Ratashak SA, Selhub J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci 93: 15227-32, 1996
  24. Jirtle RL, Sander M, Barrett JC. Genomic imprinting and environmental disease susceptibility. Environ Health Perspect 108:271-8, 2000
  25. Speer MC, Worley G, Mackey JF, et al. The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians. The NTD Collaborative Group. Neurogenetics 1:149-50, 1997
  26. Speer MC, Nye J, McLone D, et al. Possible interaction of genotypes at cystathionine beta-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects. NTD Collaborative Group. Clin Genet 56:142-4, 1999
  27. Sadler TW, Merrill AH, Stevens VL, et al. Prevention of fumonisin B1-induced neural tube defects by folic acid. Teratology 66:169-76, 2002
  28. Gaskill SJ. Primary closure of open myelomeningocele. Neurosurg Focus 16 (2):E3, 2004.
  29. Pang D. Surgical complications of open spinal dysraphism. Neurosurg Clin N Am 6:243-57, 1995
  30. Teo C, Jones R. Management of hydrocephalus by endoscopic third ventriculostomy in patients with myelomeningocele. Pediatr Neurosurg 25:57-63, 1996
  31. Warf BC, Campbell JW. Combined endoscopic third ventriculostomy and choroid plexus cauterization as primary treatment of hydrocephalus for infants with myelomeningocele: long-term results of a prospective intent-to-treat study in 115 East African infants. J Neurosurg Pediatr 2(5):310-6, 2008
  32. Pollack IF, Kinnunen D, Albright AL. The effect of early craniocervical decompression on functional outcome in neonates and young infants with myelodysplasia and symptomatic Chiari II malformations: results from a prospective series. Neurosurgery 38:703-10; discussion 10, 1996
  33. McLone DG, Dias MS. Complications of myelomeningocele closure. Pediatr Neurosurg 17:267-73, 1991
  34. Iskandar BJ, Sansone JM, Medow J, et al. The use of quick-brain magnetic resonance imaging in the evaluation of shunt-treated hydrocephalus. J Neurosurg 2004;101:147-51, 2004
  35. Abrams P, Blaivas JG, Fowler CJ, et al. The role of neuromodulation in the management of urinary urge incontinence. BJU Int 91:355-9, 2003
  36. Abrams P. Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. Urology 2003;62:28-37; discussion 40-2, 2003
  37. Pollack IF, Pang D, Albright AL, et al.Outcome following hindbrain decompression of symptomatic Chiari malformations in children previously treated with myelomeningocele closure and shunts. J Neurosurg. 1992 Dec;77(6):881-8.
  38. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167-78, 2002
  39. Abrams P, Mattiasson A, Lose GR, et al. The role of desmopressin in the treatment of adult nocturia. BJU Int 90 Suppl 3:32-6, 2002
  40. Brinker MR, Rosenfeld SR, Feiwell E, et al. Myelomeningocele at the sacral level. Long-term outcomes in adults. J Bone Joint Surg Am 76:1293-300, 1994
  41. Swank M, Dias L. Myelomeningocele: a review of the orthopaedic aspects of 206 patients treated from birth with no selection criteria. Dev Med Child Neurol 34:1047-52, 1992
  42. Williams EN, Broughton NS, Menelaus MB. Age-related walking in children with spina bifida. Dev Med Child Neurol 1999; 41(7):446-9
  43. Bowman RM, McLone DG, Grant JA, et al. Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg 34:114-20, 2001
  44. Hoppenfeld S. Congenital kyphosis in myelomeningocele. J Bone Joint Surg Br 49:276-80, 1967
  45. Main DM, Mennuti MT. Neural tube defects: issues in prenatal diagnosis and counselling. Obstet Gynecol 67:1-16, 1986
  46. Steinbok P, Irvine B, Cochrane DD, et al. Long-term outcome and complications of children born with meningomyelocele. Childs Nerv Syst 8:92-6, 1992
  47. Hall JG, Friedman JM, Kenna BA, et al. Clinical, genetic, and epidemiological factors in neural tube defects. Am J Hum Genet 43: 827-837, 1988
  48. Smith GK. The history of spina bifida, hydrocephalus, paraplegia, and incontinence. Pediatr Surg Int 2001;17:424-32.
  49. Pruitt LJ. Living with spina bifida: a historical perspective. Pediatrics 2012;130:181-3.
  50. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257-61.
  51. Zimmerman RD, Breckbill D, Dennis MW, et al. Cranial CT findings in patients with meningomyelocele. AJR Am J Roentgenol 1979;132:623-9.
  52. Talamonti G, D’Aliberti G, Collice M. Myelomeningocele: long-term neurosurgical treatment and follow-up in 202 patients. J Neurosurg 2007;107:368-86.
  53. Sarwark JF. Spina bifida. Pediatr Clin North Am 1996;43:1151-8.
  54. Rodriguez JI, Garcia M, Morales C, et al. Trisomy 13 syndrome and neural tube defects. Am J Med Genet 1990;36:513-6.
  55. Chemke J, Fishel E, Zalish M, et al. Multiple skeletal anomalies in the “13q-” syndrome. Eur J Pediatr 1978;128:27-31.
  56. Holmes LB, Driscoll SG, Atkins L. Etiologic heterogeneity of neural-tube defects. N Engl J Med 1976;294:365-9.
  57. Rabb CH, McComb JG, Raffel C, et al. Spinal arachnoid cysts in the pediatric age group: an association with neural tube defects. J Neurosurg 1992;77:369-72.
  58. Niggemann B, Buck D, Michael T, et al. Latex allergy in spina bifida: at the turning point? J Allergy Clin Immunol 2000;106:1201.
  59. Messing-Junger M, Rohrig A. Primary and secondary management of the Chiari II malformation in children with myelomeningocele. Childs Nerv Syst 2013;29:1553-62.
  60. Roach JW, Short BF, Saltzman HM. Adult consequences of spina bifida: a cohort study. Clin Orthop Relat Res 2011; 469(5):1246-52
Back to top
Recommended Readings for Myelomeningoceles in Children
Spina Bifida Occulta and Tethered Cord Syndrome in Children Homepage